182 related articles for article (PubMed ID: 23221565)
21. The mannose-dependent epitope for neutralizing antibody 2G12 on human immunodeficiency virus type 1 glycoprotein gp120.
Sanders RW; Venturi M; Schiffner L; Kalyanaraman R; Katinger H; Lloyd KO; Kwong PD; Moore JP
J Virol; 2002 Jul; 76(14):7293-305. PubMed ID: 12072528
[TBL] [Abstract][Full Text] [Related]
22. Human monoclonal antibody 2G12 defines a distinctive neutralization epitope on the gp120 glycoprotein of human immunodeficiency virus type 1.
Trkola A; Purtscher M; Muster T; Ballaun C; Buchacher A; Sullivan N; Srinivasan K; Sodroski J; Moore JP; Katinger H
J Virol; 1996 Feb; 70(2):1100-8. PubMed ID: 8551569
[TBL] [Abstract][Full Text] [Related]
23. Actinohivin, a broadly neutralizing prokaryotic lectin, inhibits HIV-1 infection by specifically targeting high-mannose-type glycans on the gp120 envelope.
Hoorelbeke B; Huskens D; Férir G; François KO; Takahashi A; Van Laethem K; Schols D; Tanaka H; Balzarini J
Antimicrob Agents Chemother; 2010 Aug; 54(8):3287-301. PubMed ID: 20498311
[TBL] [Abstract][Full Text] [Related]
24. A Trimeric HIV-1 Envelope gp120 Immunogen Induces Potent and Broad Anti-V1V2 Loop Antibodies against HIV-1 in Rabbits and Rhesus Macaques.
Jones AT; Chamcha V; Kesavardhana S; Shen X; Beaumont D; Das R; Wyatt LS; LaBranche CC; Stanfield-Oakley S; Ferrari G; Montefiori DC; Moss B; Tomaras GD; Varadarajan R; Amara RR
J Virol; 2018 Mar; 92(5):. PubMed ID: 29237847
[TBL] [Abstract][Full Text] [Related]
25. Concanavalin A binding to HIV envelope protein is less sensitive to mutations in glycosylation sites than monoclonal antibody 2G12.
Pashov A; MacLeod S; Saha R; Perry M; VanCott TC; Kieber-Emmons T
Glycobiology; 2005 Oct; 15(10):994-1001. PubMed ID: 15917430
[TBL] [Abstract][Full Text] [Related]
26. Broadly neutralizing human anti-HIV antibody 2G12 is effective in protection against mucosal SHIV challenge even at low serum neutralizing titers.
Hessell AJ; Rakasz EG; Poignard P; Hangartner L; Landucci G; Forthal DN; Koff WC; Watkins DI; Burton DR
PLoS Pathog; 2009 May; 5(5):e1000433. PubMed ID: 19436712
[TBL] [Abstract][Full Text] [Related]
27. Altering the Specificity of the Antibody Response to HIV gp120 with a Glycoconjugate Antigen.
Liu CC; Zhai C; Zheng XJ; Ye XS
ACS Chem Biol; 2016 Jun; 11(6):1702-9. PubMed ID: 27088577
[TBL] [Abstract][Full Text] [Related]
28. Kinetic mechanism for HIV-1 neutralization by antibody 2G12 entails reversible glycan binding that slows cell entry.
Platt EJ; Gomes MM; Kabat D
Proc Natl Acad Sci U S A; 2012 May; 109(20):7829-34. PubMed ID: 22547820
[TBL] [Abstract][Full Text] [Related]
29. Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans.
Zhang H; Fu H; Luallen RJ; Liu B; Lee FH; Doms RW; Geng Y
Vaccine; 2015 Sep; 33(39):5140-7. PubMed ID: 26277072
[TBL] [Abstract][Full Text] [Related]
30. Influence of novel CD4 binding-defective HIV-1 envelope glycoprotein immunogens on neutralizing antibody and T-cell responses in nonhuman primates.
Douagi I; Forsell MN; Sundling C; O'Dell S; Feng Y; Dosenovic P; Li Y; Seder R; Loré K; Mascola JR; Wyatt RT; Karlsson Hedestam GB
J Virol; 2010 Feb; 84(4):1683-95. PubMed ID: 19955308
[TBL] [Abstract][Full Text] [Related]
31. Defining criteria for oligomannose immunogens for HIV using icosahedral virus capsid scaffolds.
Astronomo RD; Kaltgrad E; Udit AK; Wang SK; Doores KJ; Huang CY; Pantophlet R; Paulson JC; Wong CH; Finn MG; Burton DR
Chem Biol; 2010 Apr; 17(4):357-70. PubMed ID: 20416507
[TBL] [Abstract][Full Text] [Related]
32. Resistance of HIV-1 to the broadly HIV-1-neutralizing, anti-carbohydrate antibody 2G12.
Huskens D; Van Laethem K; Vermeire K; Balzarini J; Schols D
Virology; 2007 Apr; 360(2):294-304. PubMed ID: 17123566
[TBL] [Abstract][Full Text] [Related]
33. Fragments of the V1/V2 domain of HIV-1 glycoprotein 120 engineered for improved binding to the broadly neutralizing PG9 antibody.
Morales JF; Yu B; Perez G; Mesa KA; Alexander DL; Berman PW
Mol Immunol; 2016 Sep; 77():14-25. PubMed ID: 27449907
[TBL] [Abstract][Full Text] [Related]
34. Fc-glycosylation influences Fcγ receptor binding and cell-mediated anti-HIV activity of monoclonal antibody 2G12.
Forthal DN; Gach JS; Landucci G; Jez J; Strasser R; Kunert R; Steinkellner H
J Immunol; 2010 Dec; 185(11):6876-82. PubMed ID: 21041724
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 gp120 determinants proximal to the CD4 binding site shift protective glycans that are targeted by monoclonal antibody 2G12.
Duenas-Decamp MJ; Clapham PR
J Virol; 2010 Sep; 84(18):9608-12. PubMed ID: 20610714
[TBL] [Abstract][Full Text] [Related]
36. STD NMR study of the interactions between antibody 2G12 and synthetic oligomannosides that mimic selected branches of gp120 glycans.
Enríquez-Navas PM; Chiodo F; Marradi M; Angulo J; Penadés S
Chembiochem; 2012 Jun; 13(9):1357-65. PubMed ID: 22628288
[TBL] [Abstract][Full Text] [Related]
37. Rationally Designed Immunogens Targeting HIV-1 gp120 V1V2 Induce Distinct Conformation-Specific Antibody Responses in Rabbits.
Jiang X; Totrov M; Li W; Sampson JM; Williams C; Lu H; Wu X; Lu S; Wang S; Zolla-Pazner S; Kong XP
J Virol; 2016 Dec; 90(24):11007-11019. PubMed ID: 27707920
[TBL] [Abstract][Full Text] [Related]
38. Multiple Antibody Lineages in One Donor Target the Glycan-V3 Supersite of the HIV-1 Envelope Glycoprotein and Display a Preference for Quaternary Binding.
Longo NS; Sutton MS; Shiakolas AR; Guenaga J; Jarosinski MC; Georgiev IS; McKee K; Bailer RT; Louder MK; O'Dell S; Connors M; Wyatt RT; Mascola JR; Doria-Rose NA
J Virol; 2016 Dec; 90(23):10574-10586. PubMed ID: 27654288
[TBL] [Abstract][Full Text] [Related]
39. DNA vaccine molecular adjuvants SP-D-BAFF and SP-D-APRIL enhance anti-gp120 immune response and increase HIV-1 neutralizing antibody titers.
Gupta S; Clark ES; Termini JM; Boucher J; Kanagavelu S; LeBranche CC; Abraham S; Montefiori DC; Khan WN; Stone GW
J Virol; 2015 Apr; 89(8):4158-69. PubMed ID: 25631080
[TBL] [Abstract][Full Text] [Related]
40. The V1V2 domain and an N-linked glycosylation site in the V3 loop of the HIV-1 envelope glycoprotein modulate neutralization sensitivity to the human broadly neutralizing antibody 2G12.
Chaillon A; Braibant M; Moreau T; Thenin S; Moreau A; Autran B; Barin F
J Virol; 2011 Apr; 85(7):3642-8. PubMed ID: 21248038
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]